ema glp-1 vision loss recommendation november 2025 Last month, the European Medicines Agency recommended that product information for #semaglutide medicines— the active ingredient in #Ozempic, #Rybelsus, and #Wegovy — be updated to include non-arteritic anterior ischemic optic neuropathy or # Emerging Concerns: GLP-1 Modulators and

Hypothyroidism and weight loss medications require careful consideration

A new meta-analysis of relevant clinical studies suggests that GLP 1 weight-loss drugs provide protection against heart attacks, strokes and premature death for up to 2.7 years

And now

Support your wellness goals with a clean, keto-inspired daily formula designed for appetite balance, energy, and metabolic support

As its use becomes more widespread, perioperative physicians and head-neck surgeons must be familiar with its pharmacokinetics and associated risks

The Danish drugmaker is making its blockbuster drug Wegovy available through the Hims platform as well as other telehealth companies LifeMD and Ro.